Patterson Companies | PDCO - Sales Revenues


Patterson Companies reported $1.57B in Sales Revenues for its fiscal quarter ending in January of 2025.



Sales Change Date
Agilent USD 1.86B 123M Sep/2025
Align Technology USD 1.05B 54.3M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Cardinal Health USD 65.63B 1.63B Dec/2025
Charles River Laboratories USD 1000M 32.14M Sep/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
CVS Health USD 105.7B 2.8B Dec/2025
Danaher USD 6.84B 790M Dec/2025
Dentsply International USD 904M 32M Sep/2025
eHealth USD 58.41M 7.45M Sep/2024
Henry Schein USD 3.34B 100M Sep/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Laboratory Of America USD 3.56B 30M Sep/2025
McKesson USD 106.16B 3.01B Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Owens Minor USD 697.26M 15.36M Sep/2025
Phibro Animal Health USD 309.26M 48.83M Dec/2024
Quest Diagnostics USD 2.81B 10M Dec/2025
Repligen USD 189M 7M Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Waters USD 932M 132M Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025
Zoetis USD 2.4B 0 Dec/2025